Decanoic acid modification enhances the antibacterial activity of PMAP-23RI-Dec

Tengfei Shen,Liangliang Chen,Yongqing Liu,Shuaibing Shi,Zhixin Liu,Kairui Cai,Chengshui Liao,Chen Wang
DOI: https://doi.org/10.1016/j.ejps.2020.105609
IF: 5.112
2021-02-01
European Journal of Pharmaceutical Sciences
Abstract:<p>Antimicrobial peptides are a new type of antibacterial drugs with a broad antibacterial spectrum. Based on our previous research, PMAP-23RI-Dec was designed by modifying the C-terminal of PMAP-23RI with decanoic acid. In this study, we measured the antibacterial activity, stability, hemolysis and cytotoxicity of PMAP-23RI-Dec. The mechanism of PMAP-23RI-Dec on biofilm and cell membranes were also studied. The results show that PMAP-23RI-Dec exhibited high antibacterial activity and stability, but the hemolytic activity and cytotoxicity of PMAP-23RI-Dec were not enhanced. Moreover, PMAP-23RI-Dec could inhibit biofilm formation at low concentrations, and enhance the killing effect on bacteria by changing the permeability of their cell membranes. Finally, PMAP-23RI-Dec reduced <em>Pseudomonas aeruginosa</em> GIM1.551 and <em>Staphylococcus aureus</em> ATCC25923 damage to organs, and showed superior efficacy against peritonitis. PMAP-23RI-Dec also reduced the scope of abscess and alleviated wound infections. Our research indicated that PMAP-23RI-Dec is a new antibacterial agent with potential clinical application.</p>
pharmacology & pharmacy
What problem does this paper attempt to address?